Literature DB >> 23761265

The mERG1a channel modulates skeletal muscle MuRF1, but not MAFbx, expression.

Amber L Pond1, Carrie Nedele, Wen-Horng Wang, Xun Wang, Claire Walther, Christine Jaeger, Kevin S Bradley, Huahua Du, Naoya Fujita, Gregory H Hockerman, Kevin M Hannon.   

Abstract

INTRODUCTION: We investigated the mechanism by which the MERG1a K+ channel increases ubiquitin proteasome proteolysis (UPP).
METHODS: Hindlimb suspension and electro-transfer of Merg1a cDNA into mouse gastrocnemius muscles induced atrophy.
RESULTS: Atrophic gastrocnemius muscles of hindlimb-suspended mice express Merg1a, Murf1, and Mafbx genes. Electrotransfer of Merg1a significantly decreases muscle fiber size (12.6%) and increases UPP E3 ligase Murf1 mRNA (2.1-fold) and protein (23.7%), but does not affect Mafbx E3 ligase expression. Neither Merg1a-induced decreased fiber size nor Merg1a-induced increased Murf1 expression is curtailed significantly by coexpression of inactive HR-Foxo3a, a gene encoding a transcription factor known to induce Mafbx expression.
CONCLUSIONS: The MERG1a K+ channel significantly increases expression of Murf1, but not Mafbx. We explored this expression pattern by expressing inactive Foxo3a and showing that it is not involved in MERG1a-mediated expression of Murf1. These findings suggest that MERG1a may not modulate Murf1 expression through the AKT/FOXO pathway.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  MAFbx; MuRF1; atrogin-1; mERG1a; skeletal muscle atrophy; ubiquitin-proteasome proteolysis

Mesh:

Substances:

Year:  2013        PMID: 23761265      PMCID: PMC4056345          DOI: 10.1002/mus.23924

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  42 in total

Review 1.  RING finger proteins: mediators of ubiquitin ligase activity.

Authors:  C A Joazeiro; A M Weissman
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

2.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

Authors:  M D Gomes; S H Lecker; R T Jagoe; A Navon; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Dominant-negative subunits reveal potassium channel families that contribute to M-like potassium currents.

Authors:  A A Selyanko; P Delmas; J K Hadley; L Tatulian; I C Wood; M Mistry; B London; D A Brown
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

4.  Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy.

Authors:  R Bridge Hunter; EricJ Stevenson; Alan Koncarevic; Heather Mitchell-Felton; David A Essig; Susan C Kandarian
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

5.  Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo.

Authors:  Mohammed Borhan Alzghoul; Dave Gerrard; Bruce A Watkins; Kevin Hannon
Journal:  FASEB J       Date:  2003-11-03       Impact factor: 5.191

6.  Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass.

Authors:  Simon W Jones; Roger J Hill; Philip A Krasney; Barbara O'Conner; Nicholas Peirce; Paul L Greenhaff
Journal:  FASEB J       Date:  2004-04-14       Impact factor: 5.191

7.  Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Authors:  Marco Sandri; Claudia Sandri; Alex Gilbert; Carsten Skurk; Elisa Calabria; Anne Picard; Kenneth Walsh; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

8.  Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents.

Authors:  Robert Ringseis; Janine Keller; Isabel Lukas; Julia Spielmann; Erika Most; Aline Couturier; Bettina König; Frank Hirche; Gabriele I Stangl; Gaiping Wen; Klaus Eder
Journal:  Biochim Biophys Acta       Date:  2012-10-04

9.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Authors:  Trevor N Stitt; Doreen Drujan; Brian A Clarke; Frank Panaro; Yekatarina Timofeyva; William O Kline; Michael Gonzalez; George D Yancopoulos; David J Glass
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

Review 10.  Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.

Authors:  David J Glass
Journal:  Nat Cell Biol       Date:  2003-02       Impact factor: 28.824

View more
  6 in total

1.  What Can be Learned from the Time Course of Changes in Low-Frequency Stimulated Muscle?

Authors:  Dirk Pette
Journal:  Eur J Transl Myol       Date:  2017-06-24

2.  Muscle Decline in Aging and Neuromuscular Disorders - Mechanisms and Countermeasures: Terme Euganee, Padova (Italy), April 13-16, 2016.

Authors: 
Journal:  Eur J Transl Myol       Date:  2016-03-31

3.  Muscle proteolytic system modulation through the effect of taurine on mice bearing muscular atrophy.

Authors:  Rania M Khalil; Walied S Abdo; Ahmed Saad; Eman G Khedr
Journal:  Mol Cell Biochem       Date:  2017-12-02       Impact factor: 3.396

4.  The Ubr2 Gene is Expressed in Skeletal Muscle Atrophying as a Result of Hind Limb Suspension, but not Merg1a Expression Alone.

Authors:  Gregory H Hockerman; Nicole M Dethrow; Sohaib Hameed; Maureen Doran; Christine Jaeger; Wen-Horng Wang; Amber L Pond
Journal:  Eur J Transl Myol       Date:  2014-03-31

5.  Zanthoxylum alkylamides ameliorate protein metabolism disorder in STZ-induced diabetic rats.

Authors:  Tingyuan Ren; Yuping Zhu; Xuejuan Xia; Yongbo Ding; Jing Guo; Jianquan Kan
Journal:  J Mol Endocrinol       Date:  2017-01-18       Impact factor: 5.098

6.  The ERG1a potassium channel increases basal intracellular calcium concentration and calpain activity in skeletal muscle cells.

Authors:  Clayton Whitmore; Evan P S Pratt; Luke Anderson; Kevin Bradley; Sawyer M Latour; Mariam N Hashmi; Albert K Urazaev; Rod Weilbaecher; Judith K Davie; Wen-Horng Wang; Gregory H Hockerman; Amber L Pond
Journal:  Skelet Muscle       Date:  2020-01-16       Impact factor: 4.912

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.